1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Digestive tract conditions
  5. Inflammatory bowel disease

Ustekinumab for the treatment of moderately to severely active Crohn's disease in children [TS ID 11955]

Topic selection

  • Project information
  • Project documents

30946-Ustekinumab-for-Crohns-Disease-V1.0-NOV2023-NON-CONF.pdf (nihr.ac.uk)